![Michael Steinmetz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Steinmetz
No open positions remaining
Profile
Dr. Michael Steinmetz is a Managing Director at Clarus Ventures LLC and a Managing Director at Clarus Lifesciences II LP.
He is on the Board of Directors at Lycera Corp., TaiGen Biopharmaceuticals Holdings Ltd., Oxford Immunotec, Inc., TaiGen Biotechnology Co., Ltd., ISB Accelerator Corp., PhysIOM LLC, CGI Pharmaceuticals, Inc., Viral Logic Systems Technology Corp., Oxford Immunotec Ltd., and Novimmune SA.
Dr. Steinmetz was previously employed as Independent Director by VBI Vaccines, Inc., Independent Director by TetraLogic Pharmaceuticals Corp., Non-Executive Director by Heptares Therapeutics Ltd., Independent Director by MacroGenics, Inc., General Partner by MPM Capital LP, Head-Biotechnology by F.
Hoffmann-La Roche Ltd., a Principal by Basel Institute for Immunology, and a Principal by California Institute of Technology.
He also served on the board at Variation Biotechnologies, Allozyne, Inc., Oxford Immunotec Global Plc, Novimmune SA, Swedish Orphan Biovitrum AB, BioXell SpA, Biovitrum AB, ESBATech AG, Accelerator Corp., Acorda Therapeutics, Inc., Homestead Clinical Corp., Intracel Corp., Intracel Resources LLC, and Virdante Pharmaceuticals, Inc.
He received his undergraduate degree from the University of Hamburg and a doctorate degree from Ludwig-Maximilians-Universität München.
Former positions of Michael Steinmetz
| Companies | Position | End |
|---|---|---|
Clarus Lifesciences II LP
 Clarus Lifesciences II LP Investment ManagersFinance Acts as Venture Capital Fund | Corporate Officer/Principal | 06/08/2016 |
Quest Diagnostics TB LLC
 Quest Diagnostics TB LLC Medical SpecialtiesHealth Technology Develops and sells clinical diagnostic products | Director/Board Member | 06/08/2016 |
ISB Accelerator Corp.
 ISB Accelerator Corp. Miscellaneous Commercial ServicesCommercial Services Involved in the study of biological systems | Director/Board Member | 06/08/2016 |
PhysIOM LLC
 PhysIOM LLC Medical/Nursing ServicesHealth Services Provides intra operative neurophysiologic monitoring services | Director/Board Member | 06/08/2016 |
Clarus Ventures LLC
 Clarus Ventures LLC Investment ManagersFinance Clarus Ventures invests in companies located in the United States. The firm focuses on companies operating in the fields of biopharmaceutical and medical technology. It participates in early stage capital transactions. Clarus Ventures acquired by Blackstone Inc on November 30, 2018. Clarus ventures will become Blackstone Life Sciences. | Private Equity Investor | 06/08/2016 |
Training of Michael Steinmetz
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
74
1st degree connections
35
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 35 |
|---|---|
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Intracel Corp.
 Intracel Corp. Pharmaceuticals: OtherHealth Technology Develops pharmaceutical products for serious viral diseases and cancer | Health Technology |
Acorda Therapeutics, Inc.
 Acorda Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops neurology therapies | Health Technology |
ISB Accelerator Corp.
ISB Accelerator Corp. Miscellaneous Commercial ServicesCommercial Services Involved in the study of biological systems | Commercial Services |
BioXell SpA
 BioXell SpA BiotechnologyHealth Technology Manufactures drugs for inflammatory diseases | Health Technology |
Homestead Clinical Corp.
 Homestead Clinical Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Allozyne, Inc.
 Allozyne, Inc. Medical SpecialtiesHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
TetraLogic Pharmaceuticals Corp.
 TetraLogic Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that focuses on discovering and developing novel small molecule therapeutics in oncology and infectious diseases | Health Technology |
Lycera Corp.
 Lycera Corp. Pharmaceuticals: MajorHealth Technology Develops novel oral medicines for treating autoimmune diseases and cancer | Health Technology |
Variation Biotechnologies (US), Inc.
 Variation Biotechnologies (US), Inc. BiotechnologyHealth Technology Develops and manufactures vaccines for infectious diseases | Health Technology |
Virdante Pharmaceuticals, Inc.
 Virdante Pharmaceuticals, Inc. Medical DistributorsDistribution Services Develops and commercializes drugs | Distribution Services |
Oxford Immunotec Global Ltd.
 Oxford Immunotec Global Ltd. Medical SpecialtiesHealth Technology Provides diagnostic and innovative tests in the field of immunology | Health Technology |
MPM BioImpact LLC
 MPM BioImpact LLC Investment ManagersFinance MPM Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of biotechnology, healthcare and life science sectors. It participates in early stage capital transactions. | Finance |
MacroGenics, Inc.
 MacroGenics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes antibody-based therapeutics for the treatment of cancer | Health Technology |
Biovitrum AB
 Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Develops pharmaceuticals and conducts medical research services | Commercial Services |
California Institute of Technology
 California Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ESBATech, a Novartis Co. GmbH
 ESBATech, a Novartis Co. GmbH Miscellaneous Commercial ServicesCommercial Services Develops antibody fragment therapeutics | Commercial Services |
Gilead Connecticut, Inc.
 Gilead Connecticut, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals and biotechnology chemicals | Health Technology |
Oxford Immunotec Ltd.
 Oxford Immunotec Ltd. Medical SpecialtiesHealth Technology Develops and sells medical diagnostic products | Health Technology |
Intracel Resources LLC
 Intracel Resources LLC BiotechnologyHealth Technology Develops vaccines, immunotherapeutic products, and cardiovascular disease research solutions | Health Technology |
University of Hamburg
 University of Hamburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TaiGen Biotechnology Co., Ltd.
 TaiGen Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of drugs | Health Technology |
PhysIOM LLC
PhysIOM LLC Medical/Nursing ServicesHealth Services Provides intra operative neurophysiologic monitoring services | Health Services |
Ludwig-Maximilians-Universität München
 Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Clarus Ventures LLC
Clarus Ventures LLC Investment ManagersFinance Clarus Ventures invests in companies located in the United States. The firm focuses on companies operating in the fields of biopharmaceutical and medical technology. It participates in early stage capital transactions. Clarus Ventures acquired by Blackstone Inc on November 30, 2018. Clarus ventures will become Blackstone Life Sciences. | Finance |
Viral Logic Systems Technology Corp.
 Viral Logic Systems Technology Corp. Pharmaceuticals: MajorHealth Technology Develops therapeutics for autoimmune and inflammatory disorders | Health Technology |
Accelerator Services Corp
 Accelerator Services Corp Investment ManagersFinance Accelerator Services invests in companies located in the United States. The firm focuses on the healthcare sector. It provides financing for early stage capital requirements. | Finance |
Nxera Pharma UK Ltd.
 Nxera Pharma UK Ltd. Pharmaceuticals: MajorHealth Technology Designs and develops new medicines targeting G protein-coupled receptors | Health Technology |
Basel Institute for Immunology
 Basel Institute for Immunology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Clarus Lifesciences II LP
Clarus Lifesciences II LP Investment ManagersFinance Acts as Venture Capital Fund | Finance |
Novimmune SA
 Novimmune SA BiotechnologyHealth Technology Operates as a drug discovery and development company | Health Technology |
TaiGen Biopharmaceuticals Holdings Ltd.
 TaiGen Biopharmaceuticals Holdings Ltd. BiotechnologyHealth Technology Develops novel therapeutics for infectious diseases, cancer, and diabetes-related complications | Health Technology |
Quest Diagnostics TB LLC
Quest Diagnostics TB LLC Medical SpecialtiesHealth Technology Develops and sells clinical diagnostic products | Health Technology |
Swedish Orphan Biovitrum AB
 Swedish Orphan Biovitrum AB Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals and orphan drugs in the areas of hematology, immunology and specialty care | Health Technology |
VBI Vaccines, Inc. /Old/
 VBI Vaccines, Inc. /Old/ BiotechnologyHealth Technology Manufactures vaccines | Health Technology |
- Stock Market
- Insiders
- Michael Steinmetz
